6 Results for "

EGFR/ErbB-2-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "EGFR/ErbB-2-IN-2" in MCE Product Catalog:

Cat. No.: HY-112420
CAS No.: 179248-61-4
Purity:  99.45%
Target:  

EGFR

Research Areas:  

Infection Metabolic Disease Cancer

EGFR/ErbB-2-IN-2 is a EGFR and ErbB inhibitor with IC50s of 0.017 μM, 0.08 μM, 1.91 μM for EGFR, ErbB-2 and ErbB-4 .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-14674
CAS No.: 383432-38-0
Purity:  98.72%
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities .
loading...
    loading...
Cat. No.: HY-E70715
Target:  

EGFR

Research Areas:  

Cancer

The erbB family comprises 4 structurally related receptors: ErbB1 (EGFR), ErbB2 (HER2-neu), ErbB3 and ErbB4. On ligand stimulation, the receptor forms either homodimers or heterodimers, which activate their cytoplasmic domain. ERBB2 775YVMA776 Recombinant Human Active Protein Kinase is a recombinant ERBB2 775YVMA776 protein that can be used to study ERBB2 775YVMA776-related functions .
loading...
    loading...
Cat. No.: HY-103439
CAS No.: 1173023-85-2
Research Areas:  

Cancer

GW 583340 dihydrochloride is an orally active ErbB-2/EGFR tyrosine kinase inhibitor. GW 583340 dihydrochloride exhibits antitumor activity in xenograft models with EGFR overexpression or ErbB-2 overexpression. GW 583340 dihydrochloride is applicable to research related to head and neck cancer, breast cancer, and gastric cancer .
loading...
    loading...
Cat. No.: HY-156639
CAS No.: 1135150-79-6
Target:  

EGFR

Research Areas:  

Cancer

EGFR/ErbB-2 inhibitor-1 is a ErbB2/HER2 inhibitor .
loading...
    loading...
Cat. No.: HY-103439A
CAS No.: 388082-81-3
Research Areas:  

Cancer

GW583340 is an orally active ErbB-2/EGFR tyrosine kinase inhibitor. GW583340 exhibits antitumor activity in xenograft models with EGFR overexpression or ErbB-2 overexpression. GW583340 is applicable to research related to head and neck cancer, breast cancer, and gastric cancer .
loading...
    loading...